NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

The North Carolina Biotechnology Center awarded 19 grants and loans totaling more than $1.5 million to universities, bioscience companies and non-profit organizations in the second quarter of its fiscal year.

The awards, made in October, November and December 2023, will support life science research, technology commercialization and entrepreneurship throughout North Carolina. The funding will also help universities and companies attract follow-on funding from other sources.

A Greensboro medical device company is poised to launch a biopsy platform that includes a needle with a proprietary and patented design that will offer physicians a more thorough, accurate and efficient tissue sampling and retrieval method.

Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has selected Sanford in Lee County as the location for its first pharmaceutical manufacturing complex in North America.

GXP-Storage, a leading provider of regulatory compliant storage solutions life sciences research, manufacturing, and healthcare-related biomedical and biodefense clients, has selected Nash County for its international headquarters. The first facility, to open in May 2024, will add over 200,000 cubic feet of secure storage space to meet the growing demand from regulated research and manufacturing activities in the Research Triangle.

The North Carolina Biotechnology Center is turning 40 years old. NCBiotech was founded in 1984, the first organization of its kind, as a catalyst for technology-based economic development in life sciences.  

As we celebrate this important milestone, it is important to take stock of where we have been, how far we have come as a life sciences hub, and where we are headed next. 

National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network, which includes a biomanufacturing plant in Durham the company acquired in 2021. 

CytexOrtho, a Durham-based pre-clinical stage medical device company working to advance orthopaedic treatment options for cartilage repair, has won the inaugural OrthoPitch Technology Competition during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Francisco.

Elo Life Systems is a step closer to making the world a little sweeter.

Robbie King, a Ph.D. geochemist, was looking for a career change.

He considered taking chemistry courses at North Carolina State University. But he ended up at the school’s Golden LEAF Biomanufacturing Training and Education Center (BTEC) instead.

King completed BTEC’s one-year certificate program in 2021 and immediately went to work for Abzena, a contract research, development and manufacturing organization in Sandford. He’s now employed by pharmaceutical giant Pfizer in quality control and analytics, supporting the company’s Sanford operations.

Drug contract development and manufacturing company Catalent Inc., with operations in the Triangle and Greenville, is expected to become a part of Novo Holdings by the end of 2024 in a $16.5 billion deal that the companies announced Monday.

The transaction, however, does not specifically involve the North Carolina operations of Novo Nordisk, the Danish pharmaceutical giant that’s 77% owned by Novo Holdings.

The Research Triangle area is the hottest spot in the nation for biomanufacturing.

That’s the pronouncement from JLL, a Fortune 500 professional services firm that specializes in real estate and investment management.

A North Carolina ag tech company is landing some major success in using a new kind of eco-friendly, portable weaponry in the global war on pests. 

Plant Health Care (PHC), a publicly traded company headquartered in Holly Springs, has received Brazilian approval to deploy its biological TEIKKO (pronounced TAKE-oh) soybean “nematicide” into that huge South American market.

As concerns mount over the climate impact of methane gas emissions, a Raleigh startup is commercializing its engineered corn that gives farmers a way to practically eliminate methane emissions from cattle.

Elysia Creative Biology is working within the existing agricultural supply chain to boost the use of corn feed that prevents methane emissions. The three-person company, founded in 2021, plans to provide its modified corn seed to farms that produce corn supplies for feed mills, which in turn sell animal feed to dairy farmers.

“Let food be your medicine and medicine be your food.”

That’s the English translation of a quote attributed to Hippocrates, the ancient Greek physician who is considered the “father of medicine.”

Around 400 BC, his “Hippocratic oath” gained traction among healers to become a code of ethics that remains a guidepost of medical practice today.

WFIRM also selected to lead AFIRM Consortium

The U.S. National Science Foundation on Friday announced two of the first-ever NSF Regional Innovation Engines (NSF Engines), both in North Carolina. 

The Piedmont Triad Regenerative Medicine Engine and the North Carolina Sustainable Textiles Innovation Engine will each initially receive up to $15 million for two years and up to $160 million over 10 years. 

scroll back to top of page